http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35234332

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1253
issn 0167-6997
1573-0646
issueIdentifier 6
pageRange 1244-1253
publicationName Investigational New Drugs
startingPage 1244
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d813a34c1e4381504d2b075a53f74917
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6a20b9245c9295bb246d84c855abdb8a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cb24aad60895a4efb767fed618c0b196
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd6785efdeba3aeb37b601f0e56136a3
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_44c48b138a275e3508213b353446a4ca
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e053629a4ad99f3a4ea04b7812e18365
bibliographicCitation Feng X, Yang G, Zhang L, Tao S, Shim JS, Chen L, Wu Q. TRIM59 guards ER proteostasis and prevents Bortezomib-mediated colorectal cancer (CRC) cells' killing. Invest New Drugs. 2022 Dec;40(6):1244–53. doi: 10.1007/s10637-022-01306-7. PMID: 36306030.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8818-6107
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_295c5cc85a292a48293827095cf3ec49
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_536fc8010dfc7628ce8a0614c432580c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f133f861f58b03bd42a350ab5d16600
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4875-5811
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_114ef0f8f743bba13f36d7acf46a8107
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae1c610fd5aa77663f55ee9ede1a46af
date 2022-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s10637-022-01306-7
https://pubmed.ncbi.nlm.nih.gov/36306030
isPartOf https://portal.issn.org/resource/ISSN/1573-0646
https://portal.issn.org/resource/ISSN/0167-6997
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title TRIM59 guards ER proteostasis and prevents Bortezomib-mediated colorectal cancer (CRC) cells’ killing
discusses http://id.nlm.nih.gov/mesh/M0460178
http://id.nlm.nih.gov/mesh/M0350110
http://id.nlm.nih.gov/mesh/M0524086
http://id.nlm.nih.gov/mesh/M000611026
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID286827

Total number of triples: 43.